Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Journal of Ultrasound|April 23, 2018
Automated classification of focal breast lesions according to S-detect: validation and role as a clinical and teaching toolMattia Di Segni, Valeria de Soccio, Vito Cantisani, et al.Future Oncology (London, England)|May 28, 2021
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trialAlessandra Fabi, Irene Terrenato, Antonello Vidiri, et al.Journal of Experimental & Clinical Cancer Research : CR|March 9, 2022
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profileMaria Laura De Angelis, Federica Francescangeli, Chiara Nicolazzo, et al.The Oncologist|October 16, 2016
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical OutcomesFrancesco Giotta, Luigi Acito, Giampiero Candeloro, et al.Clinical Breast Cancer|November 19, 2019
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational StudyBenedetta Conte, Alessandra Fabi, Francesca Poggio, et al.Journal of Personalized Medicine|December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient SeriesArmando Orlandi, Elena Iattoni, Laura Pizzuti, et al.Frontiers in Oncology|May 28, 2020
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal CancerFrancesca Belardinilli, Carlo Capalbo, Umberto Malapelle, et al.Cancers|August 27, 2021
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, et al.Cancers|January 30, 2019
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal CancerCarlo Capalbo, Francesca Belardinilli, Domenico Raimondo, et al.Cancer Biology & Therapy|November 8, 2018
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer StudyTeresa Gamucci, Laura Pizzuti, Clara Natoli, et al.Pageof 4